This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignee: National Research Institute of Chinese Medicine, Ministry of Health and Welfare. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Chia-ching Liao in Traditional Chinese Medicine
Introduction
Chia-ching Liao is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of traditional Chinese medicine, particularly in the development of plant compositions aimed at treating various health conditions, including COVID-19.
Latest Patents
Chia-ching Liao holds 2 patents that focus on innovative methods of utilizing plant compositions in medicine. His latest patents include a method for treating moderate or severe symptoms of COVID-19 using a specific plant composition. This composition comprises ingredients such as Prepared Monkshood Daughter Root, Fragrant Solomonseal Rhizome, Indian Bread, Oriental Wormwood Herb, and Baked Licorice Root and Rhizome. Additionally, he has developed a traditional Chinese medicine composition that can be used to treat pulmonary embolism or pulmonary fibrosis.
Career Highlights
Chia-ching Liao is affiliated with the National Research Institute of Chinese Medicine, which operates under the Ministry of Health and Welfare. His work at this institution has allowed him to explore and innovate within the realm of traditional medicine, contributing to the advancement of healthcare solutions.
Collaborations
Chia-ching Liao collaborates with esteemed colleagues such as Yi-chang Su and Wen-hui Chiou. Their combined expertise enhances the research and development of effective medicinal compositions.
Conclusion
Chia-ching Liao's innovative work in traditional Chinese medicine showcases the potential of plant compositions in treating serious health conditions. His contributions are paving the way for new therapeutic approaches in modern medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile